Biotech Co. Wants To Appeal Red Cross Antitrust Immunity

By Matthew Perlman

A biotech company has told a Massachusetts federal court that giving the American Red Cross immunity from claims that it smothered competition in the platelet bacteria mitigation market is unprecedented and leaves the organization free to fix prices or buy up its competitors.

 Brief attached | Read full article » | Save to favorites »